Paloma Shemirani, aged 23, passed away in July 2024 after refusing chemotherapy in favour of Gerson therapy, a controversial alternative.
Her death has ignited a heated debate about alternative cancer treatments and the dangers of rejecting mainstream medicine, and highlights the tragic consequences that can occur when unproven treatments are chosen over scientifically supported care.
